About Seed
Seed is a company based in Los Angeles (United States) founded in 2016 by Raja Dhir and Ara Katz. Seed has raised $40.62 million across 3 funding rounds from investors including TCG Ventures, The Craftory and Artis Ventures. Seed has completed 1 acquisition, including auggi. Seed operates in a competitive market with competitors including Novozymes, Ironwood Pharma, Evelo Biosciences, RedHill Biopharma and Alcresta, among others.
- Headquarter Los Angeles, United States
- Founders Raja Dhir, Ara Katz
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$40.62 M (USD)
in 3 rounds
-
Latest Funding Round
$40.62 M (USD), Series A
Apr 21, 2021
-
Investors
TCG Ventures
& 11 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Seed
Unlock access to complete
Unlock access to complete
Funding Insights of Seed
Seed has successfully raised a total of $40.62M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $40.62 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Seed
Seed has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include TCG Ventures, The Craftory and Artis Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A global investor focused on consumer packaged goods brands.
|
Locked | Locked | Locked | |
|
Early-stage startups are invested in by Artis Ventures.
|
Locked | Locked | Locked | |
|
Venture capital investments in technology and defense sectors.
|
Locked | Locked | Locked |
Investor details for Seed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Seed
Seed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include auggi.
Investment portfolio details for Seed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gut health is monitored via an AI-driven online platform.
|
Locked | Locked | 2018 | Locked |
Complete acquisition details for Seed
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Seed
Detailed financials for Seed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Seed Comparisons
Peer comparison for Seed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Seed
Seed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novozymes, Ironwood Pharma, Evelo Biosciences, RedHill Biopharma and Alcresta, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| Locked | Locked | Locked |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
Detailed competitors of Seed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Seed
Complete news archive for Seed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seed
Seed was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Seed is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Raja Dhir is the current CEO of Seed. They have also founded this company.
Seed is a funded company, having raised a total of $40.62M across 3 funding rounds to date.
Seed was founded in 2016 in Los Angeles, United States, within the biotechnology sector focused on gut health. Synbiotics are developed using metabolomic sequencing and a proprietary platform for screening host mechanistic pathways. Probiotics containing strains with GRAS or QPS status have been created, with evidence of improvements in gastrointestinal, cardiovascular, and dermatological health markers. Operations center on microbiome simulation and strain validation.
Seed's top competitors include Novozymes, Ironwood Pharma and Ardelyx.
Seed has made 1 acquisition, including auggi.
Seed has 12 investors. Key investors include TCG Ventures, The Craftory, Artis Ventures, Gisev Family Office, and Founders Fund.